Cost-effectiveness analysis of gemcitabine plus cisplatin versus fluorouracil plus cisplatin in the first-line setting for Chinese patients with metastatic nasopharyngeal carcinoma
2019 ◽
Vol 277
(2)
◽
pp. 577-584
◽
2017 ◽
Vol 20
(6)
◽
pp. 574-584
◽